Featured Research

from universities, journals, and other organizations

Drugs cut need for surgery for Crohn's disease patients by more than half

Date:
January 28, 2014
Source:
University of St George's London
Summary:
The requirement of bowel surgery is dramatically reduced by up to 60 percent in patients who develop Crohn's disease if they receive prolonged treatment with drugs called thiopurines, says a new study.

The requirement of bowel surgery is dramatically reduced by up to 60% in patients who develop Crohn's disease if they receive prolonged treatment with drugs called thiopurines, says a new study.

Related Articles


Crohn's affects more than quarter-of-a-million people in the UK leading to an inflamed intestine.

Researchers from St George's, University of London, St George's Hospital, London and Imperial College, London, monitored more than 5,000 patients in the UK living with Crohn's disease for more than 20 years and looked at the effect of thiopurine drugs that suppress inflammation in the gut.

Gastroenterologist Dr Richard Pollok, an honorary senior lecturer at St George's, University of London, said "Our discovery is timely since new guidelines from the USA have played down the benefits of these drugs in favor of newer agents.

"A year of treatment with the newer 'biologics', which are administered by injection, cost about 10,000 more compared to thiopurines.

"We try to avoid surgery but some patients face multiple procedures because the disease can flare up again particularly where the intestine has been rejoined.

"The fact that thiopurines can cut the need for surgical intervention and remain affordable is good news for patients and the NHS."

They found patients taking thiopurines, such as Azathioprine, for more than 12 months had a 60% reduction within the first 5 years of diagnosis.

Thiopurines have been used in the treatment of inflammatory bowel conditions like Crohn's disease since the 1970s but their long-term benefits have just come to light.

There has been a major increase in the number of patients who receive these drugs in the past decade and rates of surgery in patients with this condition have dropped, partly as a result of these and other treatments.

But up to a quarter of patients still go on to have their first corrective surgery to remove the worst affected areas within 5 years of being diagnosed.

The study was published in the American Journal of Gastroenterology.


Story Source:

The above story is based on materials provided by University of St George's London. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sukhdev Chatu, Sonia Saxena, Venkataraman Subramanian, Vasa Curcin, Ghasem Yadegarfar, Laura Gunn, Azeem Majeed, Richard C G Pollok. The Impact of Timing and Duration of Thiopurine Treatment on First Intestinal Resection in Crohn's Disease: National UK Population-Based Study 1989–2010. The American Journal of Gastroenterology, 2014; DOI: 10.1038/ajg.2013.462

Cite This Page:

University of St George's London. "Drugs cut need for surgery for Crohn's disease patients by more than half." ScienceDaily. ScienceDaily, 28 January 2014. <www.sciencedaily.com/releases/2014/01/140128094625.htm>.
University of St George's London. (2014, January 28). Drugs cut need for surgery for Crohn's disease patients by more than half. ScienceDaily. Retrieved March 2, 2015 from www.sciencedaily.com/releases/2014/01/140128094625.htm
University of St George's London. "Drugs cut need for surgery for Crohn's disease patients by more than half." ScienceDaily. www.sciencedaily.com/releases/2014/01/140128094625.htm (accessed March 2, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 2, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Treadmill Test Can Predict Chance Of Death Within A Decade

Treadmill Test Can Predict Chance Of Death Within A Decade

Newsy (Mar. 2, 2015) Johns Hopkins researchers analyzed 58,000 heart stress tests to come up with a formula that predicts a person&apos;s chances of dying in the next decade. Video provided by Newsy
Powered by NewsLook.com
Going Gluten-Free Could Get You A Tax Break

Going Gluten-Free Could Get You A Tax Break

Newsy (Mar. 2, 2015) If a doctor advises you to remove gluten from your diet, you could get a tax deduction on the amount you spend on gluten-free foods. Video provided by Newsy
Powered by NewsLook.com
GlaxoSmithKline and Novartis Try Swapping Success

GlaxoSmithKline and Novartis Try Swapping Success

Reuters - Business Video Online (Mar. 2, 2015) GlaxoSmithKline and Novartis have completed a series of asset swaps worth more than $20 billion. As Grace Pascoe reports they say the deal will reshape both drugmakers. Video provided by Reuters
Powered by NewsLook.com
How Can West Africa Rebuild After Ebola?

How Can West Africa Rebuild After Ebola?

Reuters - Business Video Online (Mar. 2, 2015) How best to rebuild the three West African countries struggling with Ebola will be discussed in Brussels this week. As Hayley Platt reports Sierra Leone has the toughest job ahead - its once thriving economy has been ravaged by the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins